Aster DM Healthcare
Market Cap
₹85.8b
Last Updated
2020/02/23 13:29 UTC
Data Sources
Company Financials +
Executive Summary
Aster DM Healthcare Limited operates as a healthcare company in India and internationally.
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential and fair value.
Similar Companies
Share Price & News
How has Aster DM Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ASTERDM has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-1.3%
ASTERDM
1.5%
IN Healthcare
-0.07%
IN Market
1 Year Return
12.5%
ASTERDM
33.0%
IN Healthcare
9.5%
IN Market
Return vs Industry: ASTERDM underperformed the Indian Healthcare industry which returned 33% over the past year.
Return vs Market: ASTERDM exceeded the Indian Market which returned 9.5% over the past year.
Shareholder returns
| ASTERDM | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.3% | 1.5% | -0.07% |
| 30 Day | 4.0% | 3.3% | -0.7% |
| 90 Day | 17.4% | 14.5% | 3.2% |
| 1 Year | 12.5%12.5% | 33.7%33.0% | 11.5%9.5% |
| 3 Year | n/a | 10.1%8.7% | 23.6%16.7% |
| 5 Year | n/a | 23.6%21.6% | 35.4%22.9% |
Price Volatility Vs. Market
How volatile is Aster DM Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
These 4 Measures Indicate That Aster DM Healthcare (NSE:ASTERDM) Is Using Debt Extensively2 months ago | Simply Wall St
Is Aster DM Healthcare Limited (NSE:ASTERDM) Struggling With Its 8.0% Return On Capital Employed?3 months ago | Simply Wall St
Aster DM Healthcare Limited Just Beat EPS By 21%: Here's What Analysts Think Will Happen NextValuation
Is Aster DM Healthcare undervalued compared to its fair value and its price relative to the market?
37.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ASTERDM (₹170.9) is trading below our estimate of fair value (₹272.12)
Significantly Below Fair Value: ASTERDM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ASTERDM is poor value based on its PE Ratio (24.2x) compared to the Healthcare industry average (21.6x).
PE vs Market: ASTERDM is poor value based on its PE Ratio (24.2x) compared to the Indian market (13.3x).
Price to Earnings Growth Ratio
PEG Ratio: ASTERDM is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: ASTERDM is overvalued based on its PB Ratio (3x) compared to the IN Healthcare industry average (2.1x).
Next Steps
Future Growth
How is Aster DM Healthcare forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
30.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASTERDM's forecast earnings growth (30% per year) is above the savings rate (6.5%).
Earnings vs Market: ASTERDM's earnings (30% per year) are forecast to grow faster than the Indian market (20.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ASTERDM's revenue (11.4% per year) is forecast to grow faster than the Indian market (9% per year).
High Growth Revenue: ASTERDM's revenue (11.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ASTERDM's Return on Equity is forecast to be low in 3 years time (14.7%).
Next Steps
Past Performance
How has Aster DM Healthcare performed over the past 5 years?
28.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ASTERDM has high quality earnings.
Growing Profit Margin: ASTERDM's current net profit margins (4.1%) are lower than last year (4.2%).
Past Earnings Growth Analysis
Earnings Trend: ASTERDM's earnings have grown significantly by 28.2% per year over the past 5 years.
Accelerating Growth: ASTERDM's earnings growth over the past year (13%) is below its 5-year average (28.2% per year).
Earnings vs Industry: ASTERDM earnings growth over the past year (13%) underperformed the Healthcare industry 26.2%.
Return on Equity
High ROE: ASTERDM's Return on Equity (11.3%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Aster DM Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: ASTERDM's short term assets (₹36.7B) exceed its short term liabilities (₹32.2B).
Long Term Liabilities: ASTERDM's short term assets (₹36.7B) do not cover its long term liabilities (₹47.5B).
Debt to Equity History and Analysis
Debt Level: ASTERDM's debt to equity ratio (72.4%) is considered high.
Reducing Debt: ASTERDM's debt to equity ratio has increased from 51.3% to 72.4% over the past 5 years.
Debt Coverage: ASTERDM's debt is well covered by operating cash flow (23.4%).
Interest Coverage: ASTERDM's interest payments on its debt are not well covered by EBIT (2.6x coverage).
Balance Sheet
Inventory Level: ASTERDM has a high level of physical assets or inventory.
Debt Coverage by Assets: ASTERDM's debt is covered by short term assets (assets are 1.5x debt).
Next Steps
Dividend
What is Aster DM Healthcare's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ASTERDM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ASTERDM's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ASTERDM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ASTERDM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ASTERDM's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.1yrs
Average management tenure
CEO
Mandayapurath Moopen (66yo)
5.2yrs
Tenure
₹6,000,000
Compensation
Dr. Mandayapurath Azad Moopen, M.D. is the Chairman of Aster DM Healthcare Ltd and has been its Managing Director since December 1, 2014. Dr. Moopen is Founder of Aster DM Healthcare Limited. He is a gold ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.2yrs | ₹6.00m | 0.40% ₹347.5m | |
| Group Chief Financial Officer | 7.3yrs | ₹21.50m | 0.026% ₹22.0m | |
| Group Chief Information Officer | 2.1yrs | no data | no data | |
| Company Secretary & Compliance Officer | 1.5yrs | ₹1.90m | no data | |
| Group Head of Governance & Corporate Affairs and Executive Director | 10.8yrs | no data | 0.55% ₹467.8m | |
| Deputy Managing Director & Executive Director | 6.4yrs | no data | 0.023% ₹20.0m | |
| CEO of Aster Pharmacy | 0yrs | no data | 0.036% ₹31.1m | |
| CEO of India | 6.8yrs | no data | 0.032% ₹27.7m | |
| Group Chief Medical & Quality Officer | 5yrs | no data | no data | |
| Country Head HR of Aster Hospitals & Clinics | 0yrs | no data | no data |
5.1yrs
Average Tenure
51yo
Average Age
Experienced Management: ASTERDM's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.2yrs | ₹6.00m | 0.40% ₹347.5m | |
| Group Head of Governance & Corporate Affairs and Executive Director | 10.8yrs | no data | 0.55% ₹467.8m | |
| Deputy Managing Director & Executive Director | 6.4yrs | no data | 0.023% ₹20.0m | |
| Non-Executive Director | 3.3yrs | no data | no data | |
| Non-Executive Independent Director | 4.4yrs | ₹1.20m | no data | |
| Non-Executive Independent Director | 4.8yrs | ₹600.00k | no data | |
| Additional Independent Director | 1.3yrs | ₹100.00k | no data | |
| Non-Executive Director | 10.8yrs | no data | 0.20% ₹175.2m | |
| Non-Executive Director | 4.4yrs | no data | 1.14% ₹977.2m | |
| Non-Executive Independent Director | 4.8yrs | ₹1.00m | no data |
4.8yrs
Average Tenure
58yo
Average Age
Experienced Board: ASTERDM's board of directors are considered experienced (4.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Company Information
Aster DM Healthcare Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Aster DM Healthcare Limited
- Ticker: ASTERDM
- Exchange: NSEI
- Founded: 1987
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ₹85.830b
- Shares outstanding: 502.22m
- Website: https://asterdmhealthcare.com
Number of Employees
Location
- Aster DM Healthcare Limited
- Tower D - Aspect Tower
- 33rd Floor
- Dubai
- United Arab Emirates
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 540975 | BSE (Mumbai Stock Exchange) | Yes | Equity Shares | IN | INR | Feb 2018 |
| ASTERDM | NSEI (National Stock Exchange of India) | Yes | Equity Shares | IN | INR | Feb 2018 |
Biography
Aster DM Healthcare Limited operates as a healthcare company in India and internationally. It provides primary, secondary, tertiary, and quaternary healthcare services through its 24 hospitals, 114 clinics, and 219 retail pharmacies under the Aster, Medcare, and Access brands. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/23 13:29 |
| End of Day Share Price | 2020/02/20 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.